Clinical Trial Update: A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

This is an update announcing a Phase II clinical study evaluating HLX43 in adults with advanced non-small cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• HLX43

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: RECRUITING